The digital breast tomosynthesis (DBT) market has evolved rapidly within the past year, with new vendors entering the market and recent clinical data continuing to support its use. In addition, the Centers for Medicare and Medicaid Services (CMS) created dedicated reimbursement codes for DBT procedures earlier this year.
If you enjoy this content, please share it with a colleague
- Read more about 3-D Tomosynthesis: Where Are We Now?
- Log in or register to post comments